Sun Pharma
-
{
- All
- News
- Videos
-
Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
Pantocid Tablet belongs to a class of medicines known as proton pump inhibitors (PPIs). It is primarily used to reduce the amount of acid produced in your stomach.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Australia's Mayne Pharma Sues India's Sun Pharma Over Patent Infringement
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.
-
Drug Major Sun Pharma Hit By Ransomware Attack: 5 Facts
Mumbai-based drug major Sun Pharma said on Sunday that a ransomware group has taken responsibility for the March 2 information technology security breach.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Sun Pharma Stock In Focus After Q3 Profit Falls 75%
Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'
-
Sun Pharma Q3 Profit Slides 75% To Rs 365 Crore, Misses Estimates
Total revenue from operations fell 16 per cent to 66.53 billion rupees.
-
Sun Pharma Shares Close 4% Lower As Q2 Profit Falls 60%
Shares of Sun Pharmaceutical Industries on Wednesday ended 4 per cent lower after the company reported a 59.19 per cent decline in consolidated net profit
-
Sun Pharma's Q2 Profit Plunges 59%, Beats Estimates
Profit came in at Rs 912 crore in the quarter ended September 30, compared with Rs 2,235 crore a year ago, the company said.
-
Sensex Falls For Third Day, Sun Pharma Slumps 5%
Drugmaker Sun Pharmaceutical Industries' shares slumped as much as 5 per cent to their lowest in over four years
-
Sensex Falls For Third Day; Geopolitical Tensions Spook Investors
Drugmaker Sun Pharmaceutical Industries' shares slumped as much as 5 percent to their lowest in over four years.
-
Dilip Shanghvi Overtakes Mukesh Ambani as Richest Indian
Pharma tycoon Dilip Shanghvi today surpassed Mukesh Ambani as the world's richest Indian with a net worth of $21.5 billion -- within two days of Reliance Industries chief being ranked India's wealthiest for 8th year.
-
Andhra Pradesh High Court Lifts Stay on Sun Pharma's $3.2 Billion Ranbaxy Takeover
The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to complete the deal.
-
Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal
Mumbai-based Sun Pharma will acquire troubled Indian drug maker Ranbaxy in a US$ 4 billion all-stock transaction, the company said in a statement on Monday.
-
Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
Pantocid Tablet belongs to a class of medicines known as proton pump inhibitors (PPIs). It is primarily used to reduce the amount of acid produced in your stomach.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Australia's Mayne Pharma Sues India's Sun Pharma Over Patent Infringement
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.
-
Drug Major Sun Pharma Hit By Ransomware Attack: 5 Facts
Mumbai-based drug major Sun Pharma said on Sunday that a ransomware group has taken responsibility for the March 2 information technology security breach.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Sun Pharma Stock In Focus After Q3 Profit Falls 75%
Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'
-
Sun Pharma Q3 Profit Slides 75% To Rs 365 Crore, Misses Estimates
Total revenue from operations fell 16 per cent to 66.53 billion rupees.
-
Sun Pharma Shares Close 4% Lower As Q2 Profit Falls 60%
Shares of Sun Pharmaceutical Industries on Wednesday ended 4 per cent lower after the company reported a 59.19 per cent decline in consolidated net profit
-
Sun Pharma's Q2 Profit Plunges 59%, Beats Estimates
Profit came in at Rs 912 crore in the quarter ended September 30, compared with Rs 2,235 crore a year ago, the company said.
-
Sensex Falls For Third Day, Sun Pharma Slumps 5%
Drugmaker Sun Pharmaceutical Industries' shares slumped as much as 5 per cent to their lowest in over four years
-
Sensex Falls For Third Day; Geopolitical Tensions Spook Investors
Drugmaker Sun Pharmaceutical Industries' shares slumped as much as 5 percent to their lowest in over four years.
-
Dilip Shanghvi Overtakes Mukesh Ambani as Richest Indian
Pharma tycoon Dilip Shanghvi today surpassed Mukesh Ambani as the world's richest Indian with a net worth of $21.5 billion -- within two days of Reliance Industries chief being ranked India's wealthiest for 8th year.
-
Andhra Pradesh High Court Lifts Stay on Sun Pharma's $3.2 Billion Ranbaxy Takeover
The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to complete the deal.
-
Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal
Mumbai-based Sun Pharma will acquire troubled Indian drug maker Ranbaxy in a US$ 4 billion all-stock transaction, the company said in a statement on Monday.
